Chordate Medical Holding AB Logo

Chordate Medical Holding AB

Develops a patented, drug-free neuromodulation treatment for migraine and rhinitis.

CMH | ST

Overview

Corporate Details

ISIN(s):
SE0021486131 (+1 more)
LEI:
549300R0GG2J3S0BFN79
Country:
Sweden
Address:
C/O Regus, 164 40 Kista

Description

Chordate Medical Holding AB is a medical technology company that has developed and patented Ozilia®, a CE-marked, drug-free neuromodulation treatment. The technology is indicated for the treatment of chronic migraine and chronic rhinitis. Ozilia® provides a non-pharmacological alternative to conventional medications, such as pills or injections, and is associated with minimal side effects. The company's business model is centered on building value through an extensive patent portfolio, clinical studies demonstrating efficacy, and establishing commercial success in selected markets with the goal of a future exit.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Chordate Medical Holding AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Chordate Medical Holding AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Chordate Medical Holding AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-03-14 Tommy Hedberg Other Other 2,917 11,668.00 SEK
2024-03-26 Anders Weilandt Other Buy 800,000 41,440.00 SEK
2024-03-26 Anders Weilandt Other Buy 200,000 10,540.00 SEK
2023-05-26 Anders Weilandt Other Buy 2,000,000 84,000.00 SEK
2023-05-26 Jan Hermansson Other Buy 750,000 31,500.00 SEK
2023-05-26 Nils Henrik Milton Rammer Other Other 350,000 14,700.00 SEK
2023-05-26 Caroline Brandberg Other Other 225,000 9,450.00 SEK
2023-05-26 Tommy Hedberg Other Buy 225,000 9,450.00 SEK
2023-01-09 Anders Weilandt Other Buy 3 2.10 SEK
2022-02-25 Anders Weilandt Other Buy 51,292 3,949,484.00 SEK

Peer Companies

Immunovant, Inc. Logo
Clinical-stage immunology company developing anti-FcRn antibodies for autoimmune diseases.
United States of America
IMVT
IMMUPHARMA PLC Logo
Specialty biopharmaceutical company developing peptide-based therapeutics.
United Kingdom
IMM
IMMUTEP Ltd Logo
Biotechnology company developing LAG-3 immunotherapies for cancer and autoimmune diseases.
United States of America
IMMP
IMPACT BIOMEDICAL INC. Logo
Develops biopharmaceutical products and technologies to protect against pathogens.
United States of America
IBO
INBIOGEN CO.,Ltd Logo
A life sciences firm offering bioinformatics and data mining services to biotech firms.
South Korea
101140
Incannex Healthcare Inc. Logo
A clinical-stage biopharma firm developing cannabinoid and psychedelic-based therapies.
United States of America
IXHL
Indaptus Therapeutics, Inc. Logo
Develops bacterial-based immunotherapies for cancer and viral infections.
United States of America
INDP
InflaRx N.V. Logo
Clinical-stage biopharmaceutical firm developing C5a/C5aR pathway inhibitors.
United States of America
IFRX
Inhalation Sciences Sweden AB Logo
Develops lab instruments and provides research for preclinical inhaled therapies.
Sweden
ISAB
Initiator Pharma A/S Logo
Clinical-stage company developing drugs for central and peripheral nervous system needs.
Denmark
INIT

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.